Beta Bionics, Inc. (BBNX) Institutional Ownership

Ownership Summary

Beta Bionics, Inc. (NASDAQ:BBNX) has 152 institutional investors with active 13F positions as of December 2025.

• These investors held 106.8% of outstanding shares in December 2025, down from 121.6% in September 2025.
• They decreased total shares held in Beta Bionics by -0.66% from the prior quarter, while the number of investors in BBNX stayed flat year over year.
• Activity in BBNX broke down as 102 buyers, 33 sellers, and 17 unchanged among 152 total holders.
• The aggregate institutional position in Beta Bionics amounted to 46.59Mn shares as of December 2025, down by 307.95K shares quarter on quarter, and with no net change year over year.
• As of December 31, 2025, the biggest holder of Beta Bionics is EVENTIDE ASSET MANAGEMENT, LLC at 4.99Mn shares, representing 11.45% of shares outstanding.
• The biggest buyers of Beta Bionics for the quarter ending December 2025 included HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (1.33Mn), Point72 Asset Management, L.P. (987.35K), Eversept Partners, LP (678.26K), 12 West Capital Management LP (575.0K), Goldman Sachs Group Inc (411.56K).
• The largest sellers of Beta Bionics for the quarter ending December 2025 were FARALLON CAPITAL MANAGEMENT LLC (4.31Mn), Soleus Capital Management, L.P. (1.34Mn), RTW INVESTMENTS, LP (799.19K), Omega Fund Management, LLC (603.94K), MARSHALL WACE, LLP (366.95K).
• Beta Bionics's 10 largest shareholders as of December 2025 include EVENTIDE ASSET MANAGEMENT, LLC (4.99Mn), FARALLON CAPITAL MANAGEMENT LLC (4.31Mn), Sands Capital Alternatives, LLC (3.57Mn), Morgan Stanley (3.46Mn), BlackRock, Inc. (2.91Mn), Soleus Capital Management, L.P. (2.53Mn), RTW INVESTMENTS, LP (2.5Mn), VANGUARD GROUP INC (2.22Mn), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (1.33Mn), Omega Fund Management, LLC (1.32Mn) per Business Quant data.